MyAverix Finance
NS · Healthcare
Corona Remedies Ltd (CORONA)
Pharmaceuticals & Biotechnology
Corona Remedies Ltd (CORONA) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $116.52B, P/E ratio is 63.04, dividend yield is 0.52%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CORONA
Corona Remedies Ltd (CORONA) — FAQ
What is Corona Remedies Ltd's market cap?
Corona Remedies Ltd (CORONA) has a reported market cap of $116.52B (data as of 2026-07-10).
What is CORONA's P/E ratio?
The price-to-earnings (P/E) ratio for Corona Remedies Ltd (CORONA) is 63.04 (data as of 2026-07-10).
Does Corona Remedies Ltd pay a dividend?
Corona Remedies Ltd (CORONA) shows a reported dividend yield of 0.52%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Corona Remedies Ltd in?
Corona Remedies Ltd (CORONA) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is CORONA listed on?
CORONA is listed on NS.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.